Hi jag142
As stated in the last announcement on the 1 March;
“After our initial positive experience with ADAPT® we are excited to have the choice of these 3D shaped products that will produce better reconstructions for complex aortic arch repair surgeries,” said Professor Tomasz Mroczek, from the Department of Paediatric Cardiac Surgery, University Children's Hospital, Jagiellonian University Medical College in Kraków, Poland.
-----------------------------
Great to see them starting to use them straight away or soon after getting EU approval and if the Professor has his way, Admedus could be sending a heap more of the ADAPT products their way.
They do about 365 open heart surgeries p.a at the Krakow Childrens Hospital.
Just maybe this could help the snowball to start picking up speed.....it would certainly be welcome.
Regards
Dabru
- Forums
- ASX - By Stock
- AVR
- News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-548
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.20 |
Change
-0.550(3.10%) |
Mkt cap ! $330.6M |
Open | High | Low | Value | Volume |
$17.75 | $17.75 | $16.88 | $199.1K | 11.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $17.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.24 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 17.000 |
1 | 50 | 16.900 |
1 | 5 | 16.880 |
1 | 178 | 16.850 |
1 | 250 | 16.550 |
Price($) | Vol. | No. |
---|---|---|
17.240 | 1000 | 1 |
17.400 | 1000 | 1 |
17.700 | 50 | 1 |
17.750 | 3388 | 2 |
17.800 | 200 | 1 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |